Chronic Obstructive Pulmonary Disease, An Issue of Clinics in Chest Medicine (Volume 41-3) (The Clinics: Internal Medicine, Volume 41-3)

Name: Chronic Obstructive Pulmonary Disease, An Issue of Clinics in Chest Medicine (Volume 41-3) (The Clinics: Internal Medicine, Volume 41-3)
SKU: 136638
Price: 12 USD
Availability: InStock

12 $

Format : Publisher PDF

File Size : 18.8 MB

Category: RESPIRATORY BOOKS

Description

Chronic Obstructive Pulmonary Disease, An Issue of Clinics in Chest Medicine (Volume 41-3) (The Clinics: Internal Medicine, Volume 41-3)

By Gerard Criner, Bartolome R. Celli MD
This issue of Clinics in Chest Medicine, guest-edited by Dr. Gerard Criner and Dr. Bartolome Celli, is focused on Chronic Obstructive Pulmonary Disease. Topics discussed in this issue include but are not limited to: COPD Pathogenesis; Epidemiology of COPD; Host, Gender, and Early Life Factors as Risks for COPD; Alpha One Antitrypsin Deficiency; Lung Function Testing; Assessing Symptom Burden; Chest Imaging in the Diagnosis and Assessment of the Patient with COPD; Biomarkers in the Diagnosis and Assessment of COPD; Asthma/COPD Overlap; Multimorbidity in the Patient with COPD; Definition Causes, Pathogenesis, and Consequences of Exacerbations; Treatment of Acute Exacerbations; Prevention of Exacerbations; Bronchodilators; Benefits and Risks of Inhaled Corticosteroids in COPD; Systemic Medications; Smoking Cessation/Vaccinations; Pulmonary Rehabilitation; Oxygen Therapy/Noninvasive Ventilation; and Interventional and Surgical Therapies for COPD.

Introducing a comprehensive and valuable resource on the topic of Chronic Obstructive Pulmonary Disease (COPD), this issue of Clinics in Chest Medicine is sure to be of interest to medical professionals and researchers in the field. Edited by Dr. Gerard Criner and Dr. Bartolome Celli, two esteemed experts in COPD, this issue delves into various aspects of the condition, offering insights, research findings, and treatment options to enhance patient care.

COPD is a chronic lung disease that affects millions of people worldwide. It is characterized by airflow limitation, which makes breathing increasingly difficult over time. The condition is primarily caused by long-term exposure to harmful gases or particles in the air, most commonly from tobacco smoke. COPD is a progressive disease, meaning that it worsens over time and can lead to significant disability and life-threatening complications if left untreated.

In this issue, the pathogenesis of COPD is examined, discussing the underlying mechanisms that contribute to the development and progression of the disease. The epidemiology of COPD is also explored, providing insights into the prevalence, risk factors, and burden of the condition on a global scale. Additionally, the role of host factors, gender, and early life factors in COPD risk are examined, shedding light on the potential preventive strategies and interventions.

One of the specific topics covered in this issue is alpha-1 antitrypsin deficiency, a genetic disorder that increases the risk of developing COPD. It discusses the diagnosis, management, and treatment options for individuals with this condition. Lung function testing, an essential tool in the diagnosis and assessment of COPD, is thoroughly explained, providing readers with a comprehensive understanding of the various tests and their interpretation.

Assessing symptom burden in patients with COPD is a crucial aspect of their care. This issue explores different methods and tools used to evaluate symptoms, helping clinicians optimize treatment plans and improve patients’ quality of life. Chest imaging in the diagnosis and assessment of patients with COPD is also discussed, highlighting the role of imaging techniques such as computed tomography (CT) scans in evaluating disease severity and identifying complications.

Biomarkers, which are measurable indicators of disease activity or progression, play an essential role in the diagnosis and assessment of COPD. The issue explores various biomarkers that can assist in the early detection, monitoring, and personalized treatment of COPD. It also covers the topic of asthma/COPD overlap, a condition where individuals exhibit characteristics of both asthma and COPD.

The issue also tackles the issue of multimorbidity in patients with COPD, highlighting the high prevalence of comorbidities in individuals with the condition and the impact it has on their management and outcomes. Understanding and effectively managing these comorbidities is crucial in providing comprehensive care for patients with COPD.

Exacerbations are acute worsening of symptoms in individuals with COPD, often triggered by infections or environmental factors. This issue explores the definition, causes, pathogenesis, and consequences of exacerbations, offering valuable insights into their prevention and treatment. It covers the treatment of acute exacerbations, including pharmacological interventions and non-pharmacological strategies.

Pharmacological treatment options for COPD are a significant focus of this issue. It explores bronchodilators, medications that help relax the airway muscles and improve airflow, as well as the benefits and risks of inhaled corticosteroids in COPD management. Systemic medications, such as oral or injectable medications, are also discussed, providing readers with a comprehensive understanding of the available treatment options.

Smoking cessation and vaccinations are essential in the management and prevention of COPD. This issue explores smoking cessation strategies and the role of vaccinations in reducing respiratory infections in individuals with COPD. It also covers the topic of pulmonary rehabilitation, a comprehensive program designed to improve physical and emotional well-being in individuals with chronic respiratory diseases.

Oxygen therapy and noninvasive ventilation are important interventions in individuals with advanced COPD. This issue explains the indications, benefits, and practical considerations of these therapies, helping clinicians make informed decisions and improve patient outcomes. Additionally, interventional and surgical therapies for COPD are discussed, providing insights into potential treatment options for individuals with severe or treatment-resistant COPD.

In summary, this issue of Clinics in Chest Medicine delves into the various aspects of COPD, offering valuable insights, research findings, and treatment options. Edited by Dr. Gerard Criner and Dr. Bartolome Celli, both respected experts in the field, this issue serves as a comprehensive resource for medical professionals and researchers interested in advancing their knowledge and understanding of COPD.

Published by Elsevier, this issue is available in digital format, making it easily accessible and portable for busy medical professionals. With 240 pages of valuable content, it covers a wide range of topics related to COPD, ensuring that readers gain a comprehensive understanding of this prevalent and challenging condition.

Whether you are a healthcare professional, researcher, or student interested in COPD, this issue of Clinics in Chest Medicine is a must-read. It provides the latest research and insights into the pathogenesis, diagnosis, assessment, and treatment of COPD, helping readers enhance patient care and contribute to the advancement of knowledge in the field.

Order your copy of this valuable resource today and dive into the world of COPD, gaining a deeper understanding of this complex condition and the strategies for managing it effectively.